Skip to main content
Clinical Trials/IRCT20240217061029N1
IRCT20240217061029N1
Not yet recruiting
Phase 3

Investigating the Effectiveness of the Traditional Persian Medicine Product based on the Apium Graveolens on the Sleep Quality and Quality of Life of the Community-Dwelling Elderly

Mazandaran University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mazandaran University of Medical Sciences
Enrollment
70
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Desire to Participate in the Study and Give Informed Consent
  • Age 60 Years and Older
  • Low Quality of Sleep based on the Pittsburgh Sleep Quality Standard Questionnaire (Score 5 and above)
  • Not Having Cognitive Impairment and Speech Impairment (Getting a Score of 25 or Higher on the MMSE Test)
  • Not Having Diagnosed Mental Disorders that Interfere with Sleep, such as Restless Leg Syndrome, Obstructive Sleep Apnea, and Severe Depression and Anxiety Disorders, and are Treated with Relevant Drugs
  • Not Having Dependence on any Narcotic Drugs, Sleeping Pills and Alcohol and Not Consuming These Items in the Last Month
  • Not Having any History of Allergy to Celery and Similar Compounds
  • Not Taking Drugs that Affect the Sleep\-Wake Cycle and Anticoagulants
  • Not Suffering from Physical Diseases that Affect the Sleep\-Wake Cycle, such as Cancer, Liver and Kidney Disorders, Severe Anemia that Requires Treatment, and Coronary Heart Disorders.
  • Not having Epilepsy, History of low Blood Pressure

Exclusion Criteria

  • Not Taking Medicine for 5 Consecutive Nights or 10 Alternating Nights
  • Showing any Allergic Reaction to the Drug
  • Reluctance to Cooperate
  • Leaving the Study due to Reasons such as Death and Illness
  • Unfortunate Events such as the Death of Relatives

Outcomes

Primary Outcomes

Not specified

Similar Trials